Research programme: calcitonin gene related peptide receptor antagonists - Bristol-Myers SquibbAlternative Names: BMS-694153; BMS-742413
Latest Information Update: 16 Apr 2013
At a glance
- Originator Bristol-Myers Squibb
- Class Amides; Imidazoles; Indazoles; Piperidines; Quinazolinones
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Migraine